Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C-activating G protein-coupled receptor signaling pathway.
down regulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger
down regulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating)
down regulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating)
down regulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger
down regulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)
down regulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating)
down regulation of phospholipase C-activating dopamine receptor signaling pathway
down regulation of phospholipase C-activating G-protein coupled receptor signaling pathway
down regulation of PLC-activating GPCR signaling pathway
down-regulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger
down-regulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating)
down-regulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating)
down-regulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger
down-regulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)
down-regulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating)
down-regulation of phospholipase C-activating dopamine receptor signaling pathway
down-regulation of phospholipase C-activating G-protein coupled receptor signaling pathway
down-regulation of PLC-activating GPCR signaling pathway
downregulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger
downregulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating)
downregulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating)
downregulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger
downregulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)
downregulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating)
downregulation of phospholipase C-activating dopamine receptor signaling pathway
downregulation of phospholipase C-activating G-protein coupled receptor signaling pathway
downregulation of PLC-activating GPCR signaling pathway
inhibition of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger
inhibition of G protein signaling, coupled to IP3 second messenger (phospholipase C activating)
inhibition of G protein signalling, coupled to IP3 second messenger (phospholipase C activating)
inhibition of G-protein coupled receptor signaling pathway coupled to IP3 second messenger
inhibition of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)
inhibition of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating)
inhibition of phospholipase C-activating dopamine receptor signaling pathway
inhibition of phospholipase C-activating G-protein coupled receptor signaling pathway
inhibition of PLC-activating GPCR signaling pathway
negative regulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger
negative regulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating)
negative regulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating)
negative regulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger
negative regulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)
negative regulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating)
negative regulation of phospholipase C-activating dopamine receptor signaling pathway
negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway
negative regulation of PLC-activating GPCR signaling pathway